Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin

Human Gene Therapy

Volumn 21, Issue 2, 2010, Pages 171-178

  Zhang, Wenjuan ^a   Jin, Huali ^a,b   Hu, Yanxin ^a   Yu, Yang ^a   Li, Xiaolin ^a   Ding, Zheng ^a   Kang, Youmin ^a   Wang, Bin ^a,c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

^c The Institute for Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENTARY DNA; DNA VACCINE; HUMAN INSULIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; OVALBUMIN; PROINSULIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HELPER CELL; HISTOPATHOLOGY; IMMUNIZATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNIZATION; INSULIN; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; PROINSULIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; VACCINES, DNA;

MUS;

EID: 77249104598     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.095     Document Type: Article

References (28)

1. Anderson, M.S., and Bluestone, J.A. (2005). The NOD mouse: A model of immune dysregulation. Annu. Rev. Immunol. 23, 447-485.
2. Besin, G., Gaudreau, S., Menard, M., Guindi, C., Dupuis, G., and Amrani, A. (2008). Thymic stromal lymphopoietin and thymic stromal lymphopoietin- conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes. Diabetes 57, 2107-2117.
3. Bluestone, J.A., Tang, Q., and Sedwick, C.E. (2008). T regulatory cells in autoimmune diabetes: Past challenges, future prospects. J. Clin. Immunol. 28, 677-688.
4. + T cells that prevent experimental autoimmune diabetes. J. Immunol. 176, 4608-4615.
5. - precursors. Am. J. Transplant. 4, 1614-1627.
6. 1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70-77.
7. Gale, E.A. (2002). The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353-3361.
8. Glinka, Y., Chang, Y., and Prud'homme, G.J. (2006). Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand. Mol. Ther. 14, 578-587.
9. Gottlieb, P.A., and Eisenbarth, G.S. (2002). Insulin-specific tolerance in diabetes. Clin. Immunol. 102, 2-11.
10. + T cells through TGF-b-TGF-b receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 100, 10878-10883.
11. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742.
12. Jaeckel, E., Mpofu, N., Saal, N., and Manns, M.P. (2008). Role of regulatory T cells for the treatment of type 1 diabetes mellitus. Horm. Metab. Res. 40, 126-136.
13. Jin, H., Kang, Y., Zheng, G., Xie, Q., Xiao, C., Zhang, X., Yu, Y., Zhu, K., Zhao, G., Zhang, F., Chen, A., and Wang, B. (2005). Induction of active immune suppression by co-immunization with DNA-and protein-based vaccines. Virology 337, 183-191.
14. Jin, H., Kang, Y., Zhao, L., Xiao, C., Hu, Y., She, R., Yu, Y., Du, X., Zhao, G., Ng, T., Chu, H.J., and Wang, B. (2008). Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines. J. Immunol. 180, 5360-5372.
15. Kukreja, A., and Maclaren, N.K. (1999). Autoimmunity and diabetes. J. Clin. Endocrinol. Metab. 84, 4371-4378.
16. Li, J.Y., Jin, H.L., Zhang, F.C., Du, X.G., and Wang, B. (2008). Treatment ofautoimmune ovarian diseasebyco-administration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells. J. Gene Med. 10, 810-820.
17. Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K., and Tochino, Y. (1980). Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29, 1-13.
18. McCluskie, M.J., and Davis, H.L. (1998). CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161, 4463-4466.
19. + T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes 56, 1395-1402.
20. Prud'homme, G.J., Draghia-Akli, R., and Wang, Q. (2007). Plasmid-based gene therapy of diabetes mellitus. Gene Ther. 14, 553-564.
21. Roncarolo, M.G., Bacchetta, R., Bordignon, C., Narula, S., and Levings, M.K. (2001). Type 1 T regulatory cells. Immunol. Rev. 182, 68-79.
22. Rossini, A.A. (2004). Autoimmune diabetes and the circle of tolerance. Diabetes 53, 267-275.
23. + regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 305, 51-66. (Pubitemid 47400264)
24. Shevach, E.M. (2000). Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423-449.
25. Singh, B., Read, S., Asseman, C., Malmstrom, V., Mottet, C., Stephens, L.A., Stepankova, R., Tlaskalova, H., and Powrie, F. (2001). Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200. (Pubitemid 33070218)
26. Tisch, R., Wang, B., Weaver, D.J., Liu, B., Bui, T., Arthos, J., and Serreze, D.V. (2001). Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. J. Immunol. 166, 2122-2132.
27. van Oosterhout, A.J.M., and Bloksma, N. (2005). Regulatory T-lymphocytes in asthma. Eur. Respir. J. 26, 918-932.
28. Vialettes, B., Beaume, D., and Vague,P.(1982). Auto-immunityand insulin-dependent diabetes. Diabete Metabolisme 8, 349-355.